Early detection and intervention are believed to be key to facilitating better outcomes in children with autism, yet the impact of age at treatment start on the outcome is poorly understood. While clinical traits such as language ability have been shown to predict treatment outcome, whether or not and how information at the genomic level can predict treatment outcome is unknown. Leveraging a cohort of toddlers with autism who all received the same standardized intervention at a very young age and provided a blood sample, here we find that very early treatment engagement (i.e., <24 months) leads to greater gains while controlling for time in treatment. Pre-treatment clinical behavioral measures predict 21% of the variance in the rate of skill growth during early intervention. Pre-treatment blood leukocyte gene expression patterns also predict the rate of skill growth, accounting for 13% of the variance in treatment slopes. Results indicated that 295 genes can be prioritized as driving this effect. These treatment-relevant genes highly interact at the protein level, are enriched for differentially histone acetylated genes in autism postmortem cortical tissue, and are normatively highly expressed in a variety of subcortical and cortical areas important for social communication and language development. This work suggests that pre-treatment biological and clinical behavioral characteristics are important for predicting developmental change in the context of early intervention and that individualized pre-treatment biology related to histone acetylation may be key.

Pre-treatment clinical and gene expression patterns predict developmental change in early intervention in autism / Lombardo, M. V.; Busuoli, E. M.; Schreibman, L.; Stahmer, A. C.; Pramparo, T.; Landi, I.; Mandelli, V.; Bertelsen, N.; Barnes, C. C.; Gazestani, V.; Lopez, L.; Bacon, E. C.; Courchesne, E.; Pierce, K.. - In: MOLECULAR PSYCHIATRY. - ISSN 1359-4184. - 2021:(2021). [10.1038/s41380-021-01239-2]

Pre-treatment clinical and gene expression patterns predict developmental change in early intervention in autism

Busuoli E. M.;Landi I.;Mandelli V.;Bertelsen N.;
2021-01-01

Abstract

Early detection and intervention are believed to be key to facilitating better outcomes in children with autism, yet the impact of age at treatment start on the outcome is poorly understood. While clinical traits such as language ability have been shown to predict treatment outcome, whether or not and how information at the genomic level can predict treatment outcome is unknown. Leveraging a cohort of toddlers with autism who all received the same standardized intervention at a very young age and provided a blood sample, here we find that very early treatment engagement (i.e., <24 months) leads to greater gains while controlling for time in treatment. Pre-treatment clinical behavioral measures predict 21% of the variance in the rate of skill growth during early intervention. Pre-treatment blood leukocyte gene expression patterns also predict the rate of skill growth, accounting for 13% of the variance in treatment slopes. Results indicated that 295 genes can be prioritized as driving this effect. These treatment-relevant genes highly interact at the protein level, are enriched for differentially histone acetylated genes in autism postmortem cortical tissue, and are normatively highly expressed in a variety of subcortical and cortical areas important for social communication and language development. This work suggests that pre-treatment biological and clinical behavioral characteristics are important for predicting developmental change in the context of early intervention and that individualized pre-treatment biology related to histone acetylation may be key.
2021
Lombardo, M. V.; Busuoli, E. M.; Schreibman, L.; Stahmer, A. C.; Pramparo, T.; Landi, I.; Mandelli, V.; Bertelsen, N.; Barnes, C. C.; Gazestani, V.; Lopez, L.; Bacon, E. C.; Courchesne, E.; Pierce, K.
Pre-treatment clinical and gene expression patterns predict developmental change in early intervention in autism / Lombardo, M. V.; Busuoli, E. M.; Schreibman, L.; Stahmer, A. C.; Pramparo, T.; Landi, I.; Mandelli, V.; Bertelsen, N.; Barnes, C. C.; Gazestani, V.; Lopez, L.; Bacon, E. C.; Courchesne, E.; Pierce, K.. - In: MOLECULAR PSYCHIATRY. - ISSN 1359-4184. - 2021:(2021). [10.1038/s41380-021-01239-2]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/316770
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact